A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

Brenig Therapeutics, a clinical-stage biotechnology company pioneering AI-powered small-molecule therapies for ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Paul Sinha, best known as 'The Sinnerman' on ITV show The Chase, opened up about his health challenges ahead of his return to ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The value of a recent biochemical discovery can be seen in the case of an 8-year-old boy who was playing typical sports in ...

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Public Health Specialist An emerging body of research suggests that Parkinson’s disease (PD) may be significantly underdiagnosed within Zimbabwe’s ageing population.